268 related articles for article (PubMed ID: 4391673)
1. [Action of various analeptics on the kidney].
Lareng L
Anesth Analg (Paris); 1969; 26(5):707-10. PubMed ID: 4391673
[No Abstract] [Full Text] [Related]
2. [Pharmacologic action of sympathomimetics].
Vourc'h G
Anesth Analg (Paris); 1969; 26(5):685-91. PubMed ID: 4391672
[No Abstract] [Full Text] [Related]
3. The use and misuse of pressor agents.
Smith NT; Corbascio AN
Anesthesiology; 1970 Jul; 33(1):58-101. PubMed ID: 4393417
[No Abstract] [Full Text] [Related]
4. Use of vasopressor agents to increase somatic blood flow.
Skinner DB; Camp TF; Austen WG
Arch Surg; 1967 May; 94(5):610-8. PubMed ID: 6025897
[No Abstract] [Full Text] [Related]
5. Pharmacology of pressor agents on the systemic circulation.
Ahlquist RP
Semin Drug Treat; 1973; 3(3):231-40. PubMed ID: 4360321
[No Abstract] [Full Text] [Related]
6. Vasopressors and low-flow states.
Hershey SG; Altura BM
Clin Anesth; 1974; 10(1):31-76. PubMed ID: 4149702
[No Abstract] [Full Text] [Related]
7. [Vasopressor action of some adrenergic amines in animals in experimental cardiac arrest].
Pietrobono P; Bragheri R; Berizzi GF
Acta Anaesthesiol; 1968; 19():Suppl 9:65-72. PubMed ID: 5757555
[No Abstract] [Full Text] [Related]
8. Vasopressors in obstetrics.
Levinson G; Shnider SM
Clin Anesth; 1974; 10(1):77-109. PubMed ID: 4360084
[No Abstract] [Full Text] [Related]
9. Use of sympathomimetic amines in shock.
Goldberg LI
Am Fam Physician; 1974 Jul; 10(1):80-5. PubMed ID: 4152035
[No Abstract] [Full Text] [Related]
10. Present state of alpha- and beta-adrenergic drugs I. The adrenergic receptor.
Ahlquist RP
Am Heart J; 1976 Nov; 92(5):661-4. PubMed ID: 10722
[TBL] [Abstract][Full Text] [Related]
11. Escape of mesenteric vessels from adrenergic and nonadrenergic vasoconstriction.
Ross G
Am J Physiol; 1971 Nov; 221(5):1217-22. PubMed ID: 4399394
[No Abstract] [Full Text] [Related]
12. Effect of isoproterenol on water diuresis.
Levi J; Kleeman CR
Proc Eur Dial Transplant Assoc; 1973; 10(0):422-6. PubMed ID: 4153331
[No Abstract] [Full Text] [Related]
13. Indications for adrenergic stimulators in shock.
Mills LC; Moyer JH
Int Z Klin Pharmakol Ther Toxikol; 1971 Jun; 4(4):385-95. PubMed ID: 5566718
[No Abstract] [Full Text] [Related]
14. [Action of various vasoactive amines on the normal and pathological cardiac function, mainly cardiogenic shock].
Moret PR; Megevand R; Gemperle M
Bibl Cardiol; 1966; 17():45-88. PubMed ID: 4287814
[No Abstract] [Full Text] [Related]
15. The action of vasopressors on isolated uterine arteries.
Van Nimwegen D; Dyer DC
Am J Obstet Gynecol; 1974 Apr; 118(8):1099-103. PubMed ID: 4817644
[No Abstract] [Full Text] [Related]
16. Renal and vascular actions of dopamine and their clinical significance.
Louis WJ; Sampson R
Prog Biochem Pharmacol; 1974; 9():22-8. PubMed ID: 4438380
[No Abstract] [Full Text] [Related]
17. [Effects of alpha and beta receptor simulating agents on regional myocardial blood flow].
Uchida Y; Ueda H
Saishin Igaku; 1971 Jul; 26(7):1382-3. PubMed ID: 4397777
[No Abstract] [Full Text] [Related]
18. Evaluation of the pharmacologic basis for the therapy of circulatory shock.
Moran NC
Am J Cardiol; 1970 Dec; 26(6):570-7. PubMed ID: 4398718
[No Abstract] [Full Text] [Related]
19. Dopamine versus norepinephrine: is one better?
Vincent JL; Biston P; Devriendt J; Brasseur A; De Backer D
Minerva Anestesiol; 2009 May; 75(5):333-7. PubMed ID: 19412154
[TBL] [Abstract][Full Text] [Related]
20. [Alpha-adrenergic blocking properties of metaraminol in the rat].
Lecomte J; Cession-Fossion A
C R Seances Soc Biol Fil; 1974; 168(4-5):622-3. PubMed ID: 4156187
[No Abstract] [Full Text] [Related]
[Next] [New Search]